AWM
TMO icon

Abound Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Abound Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Sell
30
-34
-53% -$16.3K ﹤0.01% 415
2026
Q1 		$31.6K Buy
64
+8
+14% +$4.34K 0.01% 319
2025
Q4 		$32.7K Sell
56
-37
-40% -$20.9K 0.01% 284
2025
Q3 		$44.9K Buy
93
+49
+111% +$22.8K 0.01% 222
2025
Q2 		$17.8K Sell
44
-6
-12% -$2.51K 0.01% 349
2025
Q1 		$24.9K Sell
50
-14
-22% -$7.58K 0.01% 266
2024
Q4 		$33.4K Sell
64
-3
-4% -$1.65K 0.01% 219
2024
Q3 		$41.4K Hold
67
– – 0.01% 201
2024
Q2 		$37K Buy
67
+1
+2% +$573 0.01% 184
2024
Q1 		$38.3K Buy
66
+7
+12% +$3.93K 0.01% 172
2023
Q4 		$31.4K Sell
59
-7
-11% -$3.39K 0.01% 198
2023
Q3 		$33.4K Sell
66
-4
-6% -$2.13K 0.01% 169
2023
Q2 		$36.5K Buy
70
+17
+32% +$9.17K 0.02% 161
2023
Q1 		$30.6K Buy
53
+11
+26% +$6.2K 0.01% 166
2022
Q4 		$23.1K Buy
42
+3
+8% +$1.59K 0.01% 174
2022
Q3 		$19.8K Buy
+39
New +$21.8K 0.01% 189

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Abound Wealth Management's TMO Position: Q2 2026 in Review

Abound Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 53% in Q2 2026, selling an estimated $16.3K and leaving 30 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #415.

Abound Wealth Management first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $44.9K in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Abound Wealth Management held 30 shares of Thermo Fisher Scientific worth $14.9K as of Q2 2026.
  • Abound Wealth Management sold 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
  • Thermo Fisher Scientific made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #415 holding.
  • Abound Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Thermo Fisher Scientific position peaked at $44.9K in Q3 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.